Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

HEXAPharmatec discovers new catechol derivatives

Feb. 7, 2020

Heparegenix identifies MAP2K4 inhibitors

Feb. 5, 2020

Gilead Sciences describes new IRAK-4 inhibitors

Feb. 3, 2020

Positive preliminary data from first patient in diverticulosis pilot trial of PGLG

Jan. 30, 2020

ALPN-101 demonstrates efficacy in preclinical models of chronic IBD

Jan. 27, 2020

AAV-ABCB4 gene therapy causes sustained reversal of PFIC3 disease biomarkers in mice

Jan. 22, 2020

SUMOylation inhibition enhances targeting of farnesoid X receptor for liver fibrosis

Jan. 20, 2020

Medshine Discovery identifies new IRAK-4 inhibitors

Jan. 16, 2020

FGF21 switches sides in pancreatitis

Jan. 13, 2020

Genentech begins phase II trial of BFKB-8488A in NASH

Jan. 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...